Autolus Therapeutics (AUTL) Cash from Investing Activities Growth (5y) (2022 - 2025)
Autolus Therapeutics (AUTL) Cash from Investing Activities Growth (5y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Autolus Therapeutics | 393.78 Mn | 93.07 Mn | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 77.89% |
| Sep 30, 2025 | 60.89% |
| Jun 30, 2025 | 109.14% |
| Mar 31, 2025 | -86.53% |
| Jun 30, 2024 | 42.14% |
| Mar 31, 2024 | 40.80% |
| Dec 31, 2023 | -16.33% |
| Sep 30, 2023 | 30.93% |
| Jun 30, 2023 | 4.31% |
| Dec 31, 2022 | 3.69% |